Medtronic (MDT) Other Non-Current Assets (2014 - 2026)
Medtronic (MDT) posted Other Non-Current Assets of $4.1 billion for Q2 2026, up 2.62% sequentially from $4.0 billion in Q1 2026, and up 15.71% YoY from $3.6 billion in Q2 2025.
Medtronic (MDT) Other Non-Current Assets (2014 - 2026) Analysis & Trends
Medtronic has reported Other Non-Current Assets for 13 years, with the latest figure at $4.1 billion in Q2 2026.
- Quarterly Other Non-Current Assets rose 15.71% year-over-year to $4.1 billion in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $4.1 billion (up 15.71% YoY) and the FY2026 annual result came in at $4.1 billion, up 15.71% from the prior year.
- Other Non-Current Assets rose to $4.1 billion in Q2 2026 per MDT's latest filing, from $4.0 billion in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $4.2 billion in Q1 2025 and troughed at $2.5 billion in Q1 2022.
- A 5-year average of $3.7 billion and a median of $3.9 billion in 2023 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2023 and 2025: Other Non-Current Assets soared 31.62% in 2023, then declined 11.74% in 2025.
- Over 5 years, Other Non-Current Assets stood at $3.1 billion in 2022, then climbed by 26.82% to $4.0 billion in 2023, then climbed by 1.19% to $4.0 billion in 2024, then retreated by 6.51% to $3.7 billion in 2025, then rose by 10.65% to $4.1 billion in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $4.1 billion, $4.0 billion, and $3.7 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.23 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 616.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 273.70 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 148.78 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | 1.08 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 24, 2026 | 4.15 Bn |
| Jan 23, 2026 | 4.04 Bn |
| Oct 24, 2025 | 3.75 Bn |
| Jul 25, 2025 | 3.59 Bn |
| Apr 25, 2025 | 3.58 Bn |
| Jan 24, 2025 | 4.25 Bn |
| Oct 25, 2024 | 4.01 Bn |
| Jul 26, 2024 | 4.06 Bn |
| Apr 26, 2024 | 4.05 Bn |
| Jan 26, 2024 | 4.04 Bn |
| Oct 27, 2023 | 3.96 Bn |
| Jul 28, 2023 | 3.91 Bn |
| Apr 28, 2023 | 3.96 Bn |
| Jan 27, 2023 | 3.14 Bn |
| Oct 28, 2022 | 3.12 Bn |
| Jul 29, 2022 | 3.09 Bn |
| Apr 29, 2022 | 3.01 Bn |
| Jan 28, 2022 | 2.52 Bn |
| Oct 29, 2021 | 2.50 Bn |
| Jul 30, 2021 | 2.41 Bn |